InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,922.80
(
0.38%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,733.85
(
1.59%
)
Post# of 252523
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 119992
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 232866

Tuesday, 06/09/2020 10:18:32 PM

Tuesday, June 09, 2020 10:18:32 PM

Post# of 252523
Re: RVNC/Botox-biosimilar info from today’s GS webcast

RVNC is eligible to receive $60-70M from MYL in clinical/regulatory milestones and as much as $250M in sales-based milestones. (These amounts are in addition to the $60M RVNC has already received from MYL.)

As far as I know, today is the first time RVNC has disclosed any details about the clinical/regulatory and sales-based milestones in this program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up